No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
QLGN Qualigen Therapeutics
- 3.9000
- -0.1400-3.47%
Close Dec 20 16:00 ET
- 3.9000
- 0.00000.00%
Post 16:09 ET
2.87MMarket Cap-0.08P/E (TTM)
4.1635High3.9000Low30.72KVolume4.0500Open4.0400Pre Close124.18KTurnover4.17%Turnover RatioLossP/E (Static)736.43KShares30.500052wk High-1.34P/B2.87MFloat Cap3.335852wk Low--Dividend TTM735.99KShs Float687487.5000Historical High--Div YieldTTM6.52%Amplitude3.3350Historical Low4.0420Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Qualigen Therapeutics Announces Regained Compliance With Nasdaq's Minimum Bid Price Requirement and the Equity Requirement
Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
Express News | Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (Nasdaq: Qlgn)
Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares
Qualigen Therapeutics | 10-Q: Q3 2024 Earnings Report
Qualigen Therapeutics Names Graydon Bensler to Board
Heat List
US
Overall
Symbol
Price
% Chg
No Data